APOTEX INC FDA Approval ANDA 201962

ANDA 201962

APOTEX INC

FDA Drug Application

Application #201962

Application Sponsors

ANDA 201962APOTEX INC

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002

Application Products

001TABLET; ORAL0.5MG0VARENICLINEVARENICLINE
002TABLET; ORAL1MG0VARENICLINEVARENICLINE

FDA Submissions

N/A; Not ApplicableORIG1TA2012-05-15

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

APOTEX INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 201962
            [companyName] => APOTEX INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"VARENICLINE","activeIngredients":"VARENICLINE","strength":"0.5MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"VARENICLINE","activeIngredients":"VARENICLINE","strength":"1MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/02\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"Not Applicable","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-06-02
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.